Wird geladen...
Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes
Medullary thyroid cancers (MTCs) are neuroendocrine tumors, which secrete calcitonin and carcinoembryonic antigen, both of which can serve as tumor markers. Extensive and accurate surgical resection is the primary treatment for MTC, whereas the use of external beam radiotherapy is limited. Moreover,...
Gespeichert in:
| Veröffentlicht in: | Cancer Manag Res |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6708888/ https://ncbi.nlm.nih.gov/pubmed/31686907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S127848 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|